PharmaShots | Incisive News in 3 Shots

Subscribe Now

Matrix-M adjuvant

Novavax's COVID-19 Vaccine Demonstrates 90.4% Efficacy in P-III PREVENT-19 Study

Novavax's COVID-19 Vaccine Demonstrates 90.4% Efficacy in P-III PREVENT-19 Study

June 15, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us